Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients.

Nussenblatt, Veronique; McLaughlin, Mary; Rehm, Catherine A; Lempicki, Richard A; Brann, Terry; Yang, Jun; Proschan, Michael; Highbarger, Helene C; Dewar, Robin L; Imamichi, Tom; Koratich, Chad; Neumann, Avidan U; Masur, Henry; Polis, Michael A; Kottilil, Shyam.
AIDS Res Hum Retroviruses; 23(11): 1354-9, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18184077